Log in to save to my catalogue

β-blockers Reverse Agonist-Induced β 2 -AR Downregulation Regardless of Their Signaling Profile

β-blockers Reverse Agonist-Induced β 2 -AR Downregulation Regardless of Their Signaling Profile

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31947522

β-blockers Reverse Agonist-Induced β 2 -AR Downregulation Regardless of Their Signaling Profile

About this item

Full title

β-blockers Reverse Agonist-Induced β 2 -AR Downregulation Regardless of Their Signaling Profile

Publisher

Switzerland

Journal title

International journal of molecular sciences, 2020-01, Vol.21 (2)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

Altered β-adrenergic receptor (β-AR) density has been reported in cells, animals, and humans receiving β-blocker treatment. In some cases, β-AR density is upregulated, but in others, it is unaffected or even reduced. Collectively, these results would imply that changes in β-AR density and β-blockade are not related. However, it has still not been c...

Alternative Titles

Full title

β-blockers Reverse Agonist-Induced β 2 -AR Downregulation Regardless of Their Signaling Profile

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_31947522

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31947522

Other Identifiers

E-ISSN

1422-0067

DOI

10.3390/ijms21020512

How to access this item